Skip to content

Aurobindo Pharma trades in red despite FDA nod to Eugia Pharma injection

Aurobindo Pharma#39;s wholly owned subsidiary company, Eugia Pharma Specialities Limited received a final approval from the US Food Drug Administration (USFDA) to manufacture and market Azacitidine for Injection, 100 mg single-dose vial.

Read More

​ Aurobindo Pharma#39;s wholly owned subsidiary company, Eugia Pharma Specialities Limited received a final approval from the US Food Drug Administration (USFDA) to manufacture and market Azacitidine for Injection, 100 mg single-dose vial. Aurobindo Pharma#39;s wholly owned subsidiary company, Eugia Pharma Specialities Limited received a final approval from the US Food Drug Administration (USFDA) to manufacture and market Azacitidine for Injection, 100 mg single-dose vial.  Moneycontrol Latest News Read More  

Leave a Reply

Generated by Feedzy
en_USEnglish
%d bloggers like this: